Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from PharmX Technologies ( (AU:PHX) ).
PharmX Technologies Limited has appointed Mark Conway as a director effective 13 March 2026, according to a filing made under Australian listing rules. The notice serves to officially record his appointment and confirm his current position regarding company securities.
The company disclosed that Conway holds no relevant interests in PharmX Technologies’ securities, either directly, indirectly, or through any related contracts at the time of his appointment. This indicates that the new director joins the board without an equity stake or contractual security interests in the company.
More about PharmX Technologies
PharmX Technologies Limited is a listed company, but the release provides no detail on its industry, products, or specific market focus. The disclosure is purely regulatory in nature and relates to changes in the company’s board composition, without operational or strategic information.
Average Trading Volume: 867,521
Technical Sentiment Signal: Buy
Current Market Cap: A$69.24M
See more insights into PHX stock on TipRanks’ Stock Analysis page.